Double-Blind Multicenter Comparison of the Efficacy and Safety of Saruplase and Urokinase in the Treatment of Acute Myocardial Infarction: Report of the SUTAMI Study Group - SUTAMI


SUTAMI was a prospective, randomized, double-blind, multicenter study of the efficacy of saruplase (recombinant unglycosylated single-chain urokinase-type plasminogen activator, the partent molecule of urokinase) versus urokinase in patients with acute ST elevation myocardial infarction.